SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001072613-19-000134
Filing Date
2019-03-13
Accepted
2019-03-13 07:23:11
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTJOSHUA MAKOWERMOHAMAD MAKHZOUMINEA 15 GP, LLCNEA PARTNERS 15, L.P.PETER J. BARRISPETER W. SONSINISCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 15, L.P. - CLEMENTIA PHARMACEUTICALS INC. 13D clementia13d_18297.htm SC 13D 384344
  Complete submission text file 0001072613-19-000134.txt   386228
Mailing Address 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 15, L.P. (Filed by) CIK: 0001629794 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5
Business Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Subject) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90071 | Film No.: 19677072
SIC: 2834 Pharmaceutical Preparations